Advertisement

Ads Placeholder
Loading...

Biodexa Pharmaceuticals Plc

BDRX•NASDAQ
Healthcare
Biotechnology
$0.87
$0.26(42.23%)
U.S. Market opens in 24h 14m

Biodexa Pharmaceuticals Plc (BDRX) Stock Overview

Explore Biodexa Pharmaceuticals Plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap732.5K
P/E Ratio-0.23
EPS (TTM)$-0.66
ROE-0.56%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.92
3 Months$2.53
1 Year Target$0.00

BDRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biodexa Pharmaceuticals Plc (BDRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.61, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.23 and a market capitalization of 732.5K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
42.23%
5-Day Change
32.26%
1-Month Change
-7.58%
3-Month Change
-64.50%
6-Month Change
-86.97%
Year-to-Date (YTD) Change
-64.50%
1-Year Change
-94.06%
3-Year Change
-99.99%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

https://www.biodexapharma.com
44 29 2048 0180
1 Caspian Point, Cardiff, NaN, CF10 4DQ

Company Facts

130 Employees
IPO DateDec 7, 2015
CountryGB
Actively Trading

Frequently Asked Questions